Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Rest of the World – Biocon

  1. Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Rest of the World  Biocon
  2. Intense competition in Europe’s denosumab biosimilars market amid launches  The Pharma Letter
  3. Samsung Bioepis announced on the 2nd that…

Continue Reading